Alamar Biosciences, Inc.
NASDAQ:ALMRBiotechnology
+$1.11 today
- Market cap
- $2.12B
- Beta
- 0.00
- P/E (TTM)
- -47.5
- EPS (TTM)
- -$0.45
Volume 0.53M
Average 0.38M
Returns on capital
Alamar Biosciences, Inc. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
18.8%
avg 9.4%
ROIC
-26.5%
avg -13.2%
ROA
-21.3%
avg -10.7%
Analysis
ROE is currently the strongest return metric at 18.8% versus its period average of 9.4%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Yuling Luo | Co-Founder, Chairman & CEO | USD 662.07K | 62 | 0 | <0.01% |
Shiping Chen | Co-Founder, COO & Director | USD 543.06K | 63 | 0 | <0.01% |
Justin J. McAnear | Chief Financial Officer | USD 235.85K | 50 | 0 | <0.01% |
John L. Brottem | General Counsel | — | 52 | 0 | <0.01% |
Carrie Mendivil | Vice President of Investor Relations & Corporate Communications | — | — | — | — |
Yiyuan Yin | Co-Founder, VP of Technology & Acting Secretary | — | — | — | — |
Anna Berdine | Senior Vice President of Marketing | — | — | — | — |
Stephen A. Williams | Chief Scientific Officer | — | 66 | — | — |
Xiao-Jun Ma | Chief Technology Officer | — | — | — | — |
Alex Forrest-Hay | Senior Vice President of Sales | — | — | — | — |
Micah Litow | Senior VP of AI & Strategic Initiatives | — | — | — | — |
Timothy O. White | President | — | 58 | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Sep 14, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$4.00M
Sells
128
$47.50M
Net Transaction Value
−$43.50M
Net selling
Most Active
Qiming Corporate GP VI, Ltd.
128 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Nov 11, 26Nov 11, 2026 | Qiming Corporate GP VI, Ltd. Indirect | Sell | $63.8K$63,832.92 |
| Nov 11, 26Nov 11, 2026 | Qiming Corporate GP VI, Ltd. Indirect | Sell | $14.9K$14,886.18 |
| Nov 11, 26Nov 11, 2026 | Qiming Corporate GP VI, Ltd. Indirect | Sell | $49.7K$49,701.96 |
| Nov 11, 26Nov 11, 2026 | Qiming Corporate GP VI, Ltd. Indirect | Sell | $1.7K$1,715.28 |
| Nov 11, 26Nov 11, 2026 | Qiming Corporate GP VI, Ltd. Indirect | Sell | $515.9K$515,914.56 |
| Nov 11, 26Nov 11, 2026 | Qiming Corporate GP VI, Ltd. Indirect | Sell | $430.9K$430,916.58 |
| Nov 11, 26Nov 11, 2026 | Qiming Corporate GP VI, Ltd. Indirect | Sell | $17.8K$17,826.66 |
| Nov 11, 26Nov 11, 2026 | Qiming Corporate GP VI, Ltd. Indirect | Sell | $1.8M$1,846,776.96 |
| Nov 3, 26Nov 3, 2026 | Qiming Corporate GP VI, Ltd. Indirect | Sell | $504.2K$504,244.30 |
| Nov 3, 26Nov 3, 2026 | Qiming Corporate GP VI, Ltd. Indirect | Sell | $2.2M$2,161,076.89 |
1–10 of 129
Summary
Insiders reported 1 buys worth $4.00M and 128 sells worth $47.50M over the last 12 months. That adds up to net selling of $43.50M. Qiming Corporate GP VI, Ltd. was the most active insider with 128 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | +41.8% (5yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Forward estimates point to Revenue at +41.8% (5yr), giving you a quick read on expected growth from here.
Competitors
Who does Alamar Biosciences, Inc. compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about ALMR's management, answered from reported figures.
Who manages ALMR?
Alamar Biosciences, Inc. (ALMR) lists 12 active executives. The top listed executive is Shiping Chen, Co-Founder, COO & Director.
Are ALMR insiders buying or selling?
Recent insider activity shows net selling of $39.65M.
Continue the stock analysis
Jump to another research area for this company.